Catalog No.:AA0011A8

13289-18-4 | Bufa-20,22-dienolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-

Name: Name:Bufa-20,22-dienolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
Brand: AABLOCKS
SKU: AA0011A8
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

≥99%

in stock

$82.00 $57.00

- +

5mg

≥99%

in stock

$340.00 $238.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA0011A8

Chemical Name:

Bufa-20,22-dienolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-

CAS Number:

13289-18-4

Molecular Formula:

C30H42O7

Molecular Weight:

514.6503

MDL Number:

MFCD03265649

SMILES:

O=CC12CCC(CC2(O)CCC2C1CCC1(C2(O)CCC1c1ccc(=O)oc1)C)OC1CCCC(O1)C

NSC Number:

93134

Properties

Computed Properties

Complexity:

1410

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

Undefined Atom Stereocenter Count:

XLogP3:

-1.7

Literature

Title: FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line.

Journal: Biochimica et biophysica acta 20101101

Title: Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives.

Journal: International immunopharmacology 20031201

Title: Exquisitely small amounts of nonglucocorticoid natural steroids suppress the human allogeneic T-cell response.

Journal: Transplantation proceedings 20010101

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS

Related Products of 13289-18-4

20987-24-0

98205-50-6

Building Blocks

More >

136326-10-8 | 5-Pyrimidinecarboxylic acid, 4-ethoxy-2-phenyl- | AA0011KD | MFCD00970053

136453-59-3 | 9H-Fluorene-9-methanol, 2,7-bis(1,1-dimethylethyl)- | AA0011T2 | MFCD03094016

1365272-70-3 | 1-Benzyl-5-bromo-6-fluorobenzotriazole | AA0011YB | MFCD17014273

136742-83-1 | 1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one | AA00127W | MFCD01549954

1369836-94-1 | 2-Fluoro-1-isopropyl-4-nitrobenzene | AA0012K3 | MFCD23135797

13720-94-0 | Ethyl 4-chloroquinoline-3-carboxylate | AA0012V5 | MFCD00173407

137376-38-6 | Carbamic acid, N-[3-(triethoxysilyl)propyl]-, 1,1-dimethylethyl ester | AA00134E | MFCD01074478

137529-43-2 | 3,4,5-Trifluoro-4'-[(trans)-4'-pentyl[1,1'-bicyclohexyl]-4-yl]-1,1'-biphenyl | AA0013ET | MFCD11053475

1378655-77-6 | Methyl 2-fluoro-5-hydroxy-4-methylbenzoate | AA0013WR | MFCD19440272

133155-89-2 | Cyclo[(αS,2S)-α-amino-η-oxo-2-oxiraneoctanoyl-L-phenylalanyl-L-phenylalanyl-(2R)-2-piperidinecarbonyl] | AA0014A0 | MFCD00900598

Tags:13289-18-4 Molecular Formula|13289-18-4 MDL|13289-18-4 SMILES|13289-18-4 Bufa-20,22-dienolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-